Omid Farokhzad, Seer CEO
Omid Farokhzad’s biotech insiders SPAC opens the deal window with $200M to play with
Omid Farokhzad’s SPAC is now in play after raising $200 million — triggering a green light for deal talks.
The Seer CEO, ex-Harvard professor and serial …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
